| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.096 | 0.1 |